Skip to main content

Month: June 2023

RCI BANQUE : FREDERIC SCHNEIDER APPOINTED AS THE INTERIM CEO OF RCI BANQUE SA

PRESS RELEASE FREDERIC SCHNEIDER APPOINTED AS THE INTERIM CEO OF RCI BANQUE SA Paris, June 13th, 2023 – The Board of Directors of RCI Banque SA, meet today and has decided to appoint Mr. Frédéric Schneider as the interim CEO of RCI Banque SA, which operates under the trade name of Mobilize Financial Services. This appointment takes effect today. This change follows the departure of Mr. João Leandro, who had been the CEO of RCI Banque SA since 2019. The appointment of Mr. Frédéric Schneider as the interim CEO of RCI Banque SA is subject to the approval from the European Central Bank. Born in 1976, Frédéric Schneider graduated from IAE, Lyon. He began his career in 2000 as a Business Controller at RCI Banque in the United Kingdom. In 2003, he became the Financial Controller at RCI Banque S.A. From 2005, Frédéric Schneider held successive...

Continue reading

NORBIT co-invests in EV charger company Enua

Enua EV charger Manufacturing of the chargers will be carried out from NORBIT’s factory in SelbuTrondheim, 13 June 2023: NORBIT ASA announces a joint investment with venture funds Sarsia and ProVenture in Enua AS, an electric vehicle (EV) charger company. This underpins NORBIT’s commitment to contribute to the green transition. Enua provides an innovative portable EV charger that simplifies charging by offering users freedom and flexibility to meet their changing needs. The NORBIT R&D team in Trondheim has supported Enua with hardware development and industrialisation. The joint investment with Sarsia and ProVenture will bring in expertise, experience, and scalability in Enua. “In Enua, we believe in a future where technology brings us closer to nature. Electric freedom is a step towards this. Teaming up with NORBIT, Sarsia...

Continue reading

GrowLife Inc.’s Bridgetown Mushrooms Releases Limited Edition “Bill Walton’s Wonder Bar” Mushroom Chocolate

Mushroom Holding Company Announces New Line of Functional Mushroom Product Backed by Basketball Hall of Famer PORTLAND, OR, June 13, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – GrowLife, Inc. (OTCQB: PHOT) today announced that its wholly-owned subsidiary Bridgetown Mushrooms (the “Company,”), a leading organic producer and supplier of fresh gourmet mushrooms, functional mushroom products, and mycology supplies, has released a limited edition functional mushroom bar—Bill Walton’s Wonder Bar. The Company and Bill Walton, Basketball Hall of Famer, announced their brand partnership in March 2023.  The limited edition dark chocolate bar infused with lion’s mane mushrooms marks the Company’s formal entrance into the burgeoning mushroom-fueled consumable market, projected to be valued at $27.6 billion in 2021 by Grandview Research. Bill...

Continue reading

Toll Brothers Announces Grand Opening of Two New Model Homes at Overlook at Town Center Community in King of Prussia, Pennsylvania

New luxury townhome community offers urban living features in a convenient suburban locationOverlook at Town Center by Toll Brothers Toll Brothers announces two newly opened model homes at Overlook at Town Center in King of Prussia, Pennsylvania.KING OF PRUSSIA, Pa., June 13, 2023 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the grand opening of its new model homes at Overlook at Town Center, the only new-construction townhome community at The Village at Valley Forge in King of Prussia, Pennsylvania, offering city-like living in a convenient suburban location. Townhome prices start in the mid-$500,000s. The highly anticipated Overlook at Town Center model homes showcase the innovative architectural designs for the second phase of the community, complemented...

Continue reading

Eviden launches “AIsaac Cyber Mesh”, strengthened by AWS, for reinforced cyber resilience

Press Release Eviden launches “AIsaac Cyber Mesh”, strengthened by AWS, for reinforced cyber resilience “re:Inforce”, Anaheim, California and Paris, France – June 13, 2023 – Eviden, an Atos business, a leader in digital, cloud, big data and security, today announces AIsaac Cyber Mesh, a next generation of cybersecurity detection and response, reinforced by Amazon Web Services (AWS) Security Data Lake and powered by generative AI technologies. AIsaac Cyber Mesh offers an advanced end-to-end detection, response, and recovery solution, built on a cybersecurity mesh-enabled architecture1using generative AI and predictive analytics. Combined with Amazon Security Lake, which centralizes data from multiple sources including on-premises and custom sources, AIsaac Cyber Mesh enables businesses to have a more complete understanding of the scope...

Continue reading

BIO-key Regains Compliance with Nasdaq Rule Requiring Timely Filing of Periodic Financial Reports Following Filing of its Q1’23 Form 10-Q with SEC

WALL, N.J., June 13, 2023 (GLOBE NEWSWIRE) — BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), announced today that following the filing of its Form 10-Q for the quarter ended March 31, 2023, The Nasdaq Stock Market, LLC has informed the Company that it has regained compliance with Nasdaq Listing Rule 5250(c)(1) which requires the timely filing of all required periodic financial reports with the Securities and Exchange Commission. The Company’s Form 10-Q filing was delayed because the compilation and review of certain financial information could not be completed within the prescribed time period without unreasonable effort and expense. About BIO-key International, Inc. (www.BIO-key.com)BIO-key is...

Continue reading

U.S. FDA approves Bylvay® for patients living with cholestatic pruritus due to Alagille syndrome

Approval heralds the second rare cholestatic liver disease indication for Bylvay in the U.S. after progressive familial intrahepatic cholestasis related pruritus in 2021 Immediate U.S. commercial launch and availability for eligible patients ASSERT clinical study demonstrated efficacy of Bylvay in improvement of pruritus. Also showed improvement in certain sleep disturbances and reduction in bile acids – which were secondary endpoints – with a low drug-related diarrhea rate in patients with Alagille syndrome Committee for Medicinal Products for Human Use opinion expected in Q2 2023 with final European Medicines Agency decision in second half of 2023PARIS, FRANCE, 13 June 2023 – Ipsen (Euronext: IPN: ADR: IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has approved Bylvay® (odevixibat) for the treatment of cholestatic...

Continue reading

First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $2.4 Million Gross Proceeds Priced At-the-Market

BOCA RATON, Fla., June 13, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (“First Wave BioPharma” or the “Company”) (NASDAQ: FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced it has entered into agreements with certain holders of its existing warrants exercisable for 1,681,667 shares of its common stock, in the aggregate, to exercise their warrants at a reduced exercise price of $1.15 per share, in exchange for new warrants as described below. The aggregate gross proceeds from the exercise of the existing warrants is expected to total approximately $2.4 million, before deducting financial advisory fees. The reduction in the exercise price of the existing warrants and the issuance of the new warrants...

Continue reading

Totalbankens repræsentantskab bakker op om fusion

Totalbankens repræsentantskab bakker op om fusionen af Totalbanken og Sparekassen Danmark Totalbankens repræsentantskab har på et ekstraordinært repræsentantskabsmøde dags dato behandlet bestyrelsens forslag om en fusion af Totalbanken A/S (”Totalbanken”) og Sparekassen Danmark (”Sparekassen”) med Sparekassen som det fortsættende pengeinstitut. For nærmere oplysninger om den foreslåede fusion henvises til selskabsmeddelelse nr. 8/2023.Attachment2023-10 Totalbankens repræsentantskab bakker op om fusionen 20230613

Continue reading

Correction, inside information: Aspo’s subsidiary Leipurin signs a sale and lease back agreement for its property in Tyresö, Sweden

Aspo PlcInside informationJune 13, 2023, at 7.45 p.m. Correction: This stock exchange release includes the same inside information that was incorrectly made public through a press release on June 12, 2023, at 10:15 p.m. Correction, inside information: Aspo’s subsidiary Leipurin signs a sale and lease back agreement for its property in Tyresö, Sweden Aspo’s subsidiary Leipurin has signed a sale and lease back agreement for its property in Tyresö, Sweden. The property came into Leipurin’s ownership via the Kobia acquisition that took place on 1 September 2022. The buyer of the property is Revelop, a Swedish real estate investor. With this transaction, Leipurin completes the program to sell and lease back the three properties it obtained in the Kobia acquisition. The aggregated sales price of the Gothenburg, Hässleholm and Tyresö properties...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.